Turning Point Benefit Group, Inc. Novartis Ag Transaction History
Turning Point Benefit Group, Inc.
- $166 Billion
- Q3 2025
A detailed history of Turning Point Benefit Group, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Turning Point Benefit Group, Inc. holds 4 shares of NVS stock, worth $526. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4Holding current value
$526% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NVS
# of Institutions
1,601Shares Held
137MCall Options Held
1.55MPut Options Held
2.22M-
Dodge & Cox San Francisco, CA10.6MShares$1.39 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA9.34MShares$1.23 Billion0.95% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.84MShares$1.16 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.73MShares$1.02 Billion0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.24MShares$952 Million0.34% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $283B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...